These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 3390555

  • 1. Iron balance and the management of iron overload in beta-thalassemia intermedia.
    Pippard MJ, Weatherall DJ.
    Birth Defects Orig Artic Ser; 1988; 23(5B):29-33. PubMed ID: 3390555
    [No Abstract] [Full Text] [Related]

  • 2. [Evaluation of iron balance in homozygous beta-thalassemia subjects treated with desferrioxamine administered subcutaneously].
    Ferrara M, Galdo Capotorti M, Ponte G, Esposito L.
    Pediatria (Napoli); 1983; 91(4):371-7. PubMed ID: 6545400
    [No Abstract] [Full Text] [Related]

  • 3. Iron status in thalassemia major patients after long-term subcutaneous desferrioxamine.
    Kontopoulou-Griva I, Hatzidimitriou-Papazacharia K, Spiliotopoulou J, Tsagarakis N, Digenopoulou E.
    Birth Defects Orig Artic Ser; 1988; 23(5B):111-6. PubMed ID: 3390532
    [No Abstract] [Full Text] [Related]

  • 4. [Chelating therapy in beta-thalassemia].
    Musumeci S, Romeo MA, Di Gregorio F, Schiliró G, Russo G.
    Pediatr Med Chir; 1982; 4(1-2):55-9. PubMed ID: 7111040
    [Abstract] [Full Text] [Related]

  • 5. [Thalassemia major: chelating therapy with deferoxamine].
    Abreu de Miani MS, Sanchis de Herrlein MS, Peñalver JA.
    Medicina (B Aires); 1985; 45(3):231-4. PubMed ID: 3841934
    [No Abstract] [Full Text] [Related]

  • 6. [Role and therapeutic use of deferoxamine in iron overload due to thalassemia (author's transl)].
    Lévy G, Bachelot C, Joannard A, Bost M.
    Arch Fr Pediatr; 1980 May; 37(5):299-303. PubMed ID: 7469704
    [Abstract] [Full Text] [Related]

  • 7. Pathogenesis and management of iron overload in thalassemia.
    Hershko C.
    Haematologica; 1975 Jun; 60(2):241-8. PubMed ID: 808456
    [No Abstract] [Full Text] [Related]

  • 8. Iron absorption in non-transfused iron loading anaemias: prediction of risk for iron loading, and response to iron chelation treatment, in beta thalassaemia intermedia and congenital sideroblastic anaemias.
    Pippard MJ, Weatherall DJ.
    Haematologia (Budap); 1984 Jun; 17(1):17-24. PubMed ID: 6724353
    [Abstract] [Full Text] [Related]

  • 9. [Changes in urinary iron in thalassemia major in relation to the administration of desferrioxamine].
    Esposito L, Ferrara M, Galdo Capotorti M.
    Pediatria (Napoli); 1978 Mar 31; 86(1):69-76. PubMed ID: 683795
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Desferrioxamine-induced iron outputs in Cooley's anemia. Results and perspectives.
    Cantore N, Tortarolo M, Volpe E, Gonnella F, Valente A, Buonanno G.
    Haematologica; 1981 Apr 31; 66(2):196-207. PubMed ID: 6791996
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Iron absorption in the thalassemia syndromes and its inhibition by tea.
    de Alarcon PA, Donovan ME, Forbes GB, Landaw SA, Stockman JA.
    N Engl J Med; 1979 Jan 04; 300(1):5-8. PubMed ID: 758174
    [Abstract] [Full Text] [Related]

  • 17. Outcomes, utilization, and costs among thalassemia and sickle cell disease patients receiving deferoxamine therapy in the United States.
    Delea TE, Hagiwara M, Thomas SK, Baladi JF, Phatak PD, Coates TD.
    Am J Hematol; 2008 Apr 04; 83(4):263-70. PubMed ID: 17924547
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Iron absorption in iron-loading anaemias: Effect of subcutaneous desferrioxamine infusions.
    Pippard MJ, Callender ST, Warner GT, Weatherall DJ.
    Lancet; 1977 Oct 08; 2(8041):737-9. PubMed ID: 71542
    [Abstract] [Full Text] [Related]

  • 20. Subcutaneous diethylene triamine pentaacetic acid: comparison with desferrioxamine in thalassemic patients with iron overload.
    Pippard MJ, Jackson MJ, Modell CB.
    Birth Defects Orig Artic Ser; 1988 Oct 08; 23(5B):105-9. PubMed ID: 3390531
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.